Evaluation of adjuvant chemotherapy irinotecan + 5-fluorouracil + leucovorine in advanced colorectal cancer

Acta Chirurgica Belgica

Volumn 107, Issue 3, 2007, Pages 297-301

  Kulig, J ^a   Popiela, T ^a   Richter, P ^a   Klek, S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

5 fluorouracil; Chemotherapy; Colorectal cancer

Indexed keywords

EID: 34547315254     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2007.11680060     Document Type: Review

References (20)

1. American Cancer Society. Colorectal Facts & Figures Special Edition 2005. Atlanta : American Cancer Society, 2005 Available at : http://www cancer org 2005.
2. VALONE F. H., FRIEDMAN M. A., WITTLINGER P. S., DRAKES T., EISENBERG P. D., MALEC M. et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, highdose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin : a randomized trial of the Northern California Oncology Group. J Clin Oncol, 1989, 7 (10): 1427-1436.
3. MAYER R. J. Moving beyond fluorouracil for colorectal cancer. N Engl J Med, 2000, 343 (13): 963-964.
4. BUROKER T. R., O'CONNELL M. J., WIEAND H. S., KROOK J. E., GERSTNER J. B., MAILLIARD J. A. et al. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol, 1994, 12 (1): 14-20.
5. ACCMP. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer : evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol, 1992, 10 (6): 896-903.
6. KELLY H., GOLDBERG R. M. Systemic therapy for metastatic colorectal cancer : current options, current evidence. J Clin Oncol, 2005, 23 (20): 4553-4560.
7. BLEIBERG H. CPT-11 in gastrointestinal cancer. Eur J Cancer, 1999, 35 (3): 371-379.
8. JAXEL C., KOHN K. W., WANI M. C., WALL M. E., POMMIER Y. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I : evidence for a specific receptor site and a relation to antitumor activity. Cancer Res, 1989, 49 (6): 1465-1469.
9. JAXEL C., TAUDOU G., PORTEMER C., MIRAMBEAU G., PANIJEL J., DUGUET M. Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes. Biochemistry, 1988, 27 (1): 95-99.
10. DOUILLARD J. Y., CUNNINGHAM D., ROTH A. D., NAVARRO M., JAMES R. D., KARASEK P. et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer : a multicentre randomised trial. Lancet, 2000, 355 (9209): 1041-1047.
11. DOUILLARD J. Y. Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer. Oncology (Williston Park), 2000, 14 (12 Suppl 14): 51-55.
12. SALTZ L. B., COX J. V., BLANKE C., ROSEN L. S., FEHRENBACHER L., MOORE M. J. et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med, 2000, 343 (13): 905-914.
13. TOURNIGAND C., ANDRE T., ACHILLE E., LLEDO G., FLESH M., MERY-MIGNARD D. et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer : a randomized GERCOR study. J Clin Oncol, 2004, 22 (2): 229-237.
14. HWANG J. J, EISENBERG S. G, MARSHALL J. L. Improving the toxicity of irinotecan/5-FU/leucovorin : a 21-day schedule. Oncology, 2003, 17 (suppl): 37-44.
15. CSR. Clinical Study Report. Sponsor 2005.
16. IVESON T. J., HICKISH T., SCHMITT C., VAN CUTSEM E. Irinotecan in second-line treatment of metastatic colorectal cancer : improved survival and cost-effect compared with infusional 5-FU. Eur J Cancer, 1999 Dec, 35 (13): 1796-804.
17. MOERTEL C.G. Chemotherapy for colorectal cancer. N Engl J Med, 1994, 330 (16): 1136-1142.
18. WILKES G. M. Therapeutic options in the management of colon cancer : 2005 update. Clin J Oncol Nurs, 2005 Feb, 9 (1): 31-44.
19. ANDRE T., LOUVET C., DE GRAMONT A. Colon cancer : what is new in 2004 ? Bull Cancer, 2004 Jan,91 (1): 75-80.
20. GOLDBERG R. M., SARGENT D. J., MORTON R. F., FUCHS C. S., RAMANATHAN R. K., WILLIAMSON S. K. et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol, 2004, 22 (1): 23-30.